论文部分内容阅读
目的分析低分子肝素对慢性肺源性心脏病急性加重期的治疗疗效。方法 70例慢性肺心病患者随机分为两组,35例抗凝组常规治疗基础上加用低分子肝素钠4 250 U皮下注射,2次/d,连续7 d,对照组35例只给予常规治疗。结果抗凝组治疗有效率明显高于对照组。结论应用低分子肝素抗凝治疗对慢性肺心病急性加重期安全有效。
Objective To analyze the therapeutic effect of low molecular weight heparin on acute exacerbation of chronic cor pulmonale. Methods Seventy patients with chronic cor pulmonale were randomly divided into two groups. 35 cases of anticoagulation group were treated with low molecular weight heparin sodium 4 250 U subcutaneously twice a day for 7 days, 35 cases in control group were given conventional treatment. Results The effective rate of anticoagulant therapy was significantly higher than that of the control group. Conclusion Low molecular weight heparin anticoagulant therapy is safe and effective in acute exacerbation of chronic pulmonary heart disease.